Endocrine care of transpeople part I. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transmen

  title={Endocrine care of transpeople part I. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transmen},
  author={Maria Cristina Meriggiola and Giulia Gava},
  journal={Clinical Endocrinology},
Gender dysphoria (GD) is characterized by discomfort with the assigned or birth gender and the urge to live as a member of the desired sex. The goal of medical and surgical treatment is to improve the well‐being and quality of life of transpeople. The acquisition of phenotypic features of the desired gender requires the use of cross‐sex hormonal therapy (CHT). Adult transmen are treated with testosterone to induce virilization. In adolescents with severe and persistent GD, consideration can be… 

Endocrinology of Transgender Medicine.

Recent data on hormonal treatment of transgender people and its effect on physical, psychological, and mental health is reviewed to provide evidence as to the effect of gender-affirming treatment in the nonbinary population.

Hormone therapy in female-to-male transgender patients: searching for a lifelong balance

Total T, free T, and LH dosages are shown to be reliable markers of correct androgenization and the side effects and thromboembolic, metabolic, and cardiovascular risks of androgen therapy, even in the long term, appear to be irrelevant.

Contraception across transgender

Transgender men and women need to be counseled concerning contraceptive options and potential effects of treatment on reproductive function before initiating gender-affirming hormonal treatments (GAHTs), which may induce a varying degree of reversible loss of fertility.

Endocrine treatment of transgender individuals: current guidelines and strategies

This review summarizes gender affirming medical and surgical care available to transgender individuals, along with proposals to improve medically and culturally appropriate care.

Medical Transition for Gender Diverse Patients

High-quality, long-term studies on the effectiveness and safety of various gender-affirming hormone treatment regimens are lacking, but the currently available evidence suggests that it is overall safe and effective with appropriate oversight.

Transgender patients and the role of the coagulation clinician

This work will review common referral questions and the available data and their limitations for the use of hormonal therapy in transgender patients focusing on the risk of venous thromboembolism.

Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review

The quality of evidence was low, given the lack of randomized clinical/controlled trials and the small sample sizes, and exogenous testosterone administration to transgender men was associated with modest increases in BMI, hemoglobin/hematocrit, and LDL‐cholesterol, and with decreases in HDL‐ch cholesterol.

Terapia hormonal en la transición femenino a masculino (ftm), androgénica, para trans masculino o para hombre transgénero

Hormonal Therapy of the female to male transition (FTM) is focused only on people who transit from woman to man, or male trans, male transgender.

Fertility preservation for transgender adolescents and young adults: a systematic review.

From a synthesis of the literature, it is concluded that there are many barriers preventing TAYAs from pursuing FP, including a lack of awareness of FP options, high costs, invasiveness of the available procedures and the potential psychological impact of the FP process.

Bone health in transgender people: a narrative review

To evaluate the risk of osteoporosis, it is mandatory to define the most appropriate reference group not only taking into consideration the medical aspects but also in respect of the selected gender identity of each person.



Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.

Current treatment modalities were effective and carried a low risk for side effects and adverse events at short-time follow-up, and side effects, adverse events, and desired clinical changes were examined.

Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects

Preliminary findings suggest that a decrease in height velocity and bone maturation occurs, and GnRHa treatment appears to be an important contribution to the clinical management of gender identity disorder in transsexual adolescents.

Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study.

A positive effect of hormone therapy on transsexuals' QoL is suggested after accounting for confounding factors, which will be useful for healthcare providers of transgender persons but should be confirmed with larger samples using a prospective study design.

Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.

The range of treatment used by transsexual people, the rationale behind these, and the expectation from such treatment are discussed, as well as the potential adverse effects of cross-sex hormone treatment of transsexual people.

Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals.

The data suggest that exogenous T administration does not stimulate endometrial proliferation in FtM transsexuals and indeed may have atrophic effects.

Long-term cross-sex hormone treatment is safe in transsexual subjects.

It is suggested that mortality is increased among transsexuals although due to causes unrelated to cross sex replacement therapy, which will benefit the care and treatment of these subjects.

Management of transgenderism.

Hormone treatment for both FTM and MTF can be started in early puberty, although long-term effects are not known, and all patients considering treatment need counseling and medical monitoring.

Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective.

These guidelines are structured to provide evidence-based suggestions or, where evidence is lacking, expert recommendations on diagnostic procedures and hormonal treatment in adolescent and adult transsexuals, including long-term care and eligibility for surgery.

A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.

The increased mortality in hormone-treated MtF transsexuals was mainly due to non-hormone-related causes, but ethinyl estradiol may increase the risk of cardiovascular death, and use of testosterone in doses used for hypogonadal men seemed safe.

Endocrinologic treatment of gender identity disorders.

Physicians caring for patients with transsexualism should have a general knowledge about the diagnosis, available treatment, and monitoring for complications of hormonal therapy.